Work

Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: A phase II study of the Gynecologic Oncology Group

Year: 2010

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2010.11.012

Authors: Bradley J. Monk, Michael W. Sill, Parviz Hanjani, Robert Edwards, Jacob Rotmensch, Koen De Geest, Albert J. Bonebrake, Joan L. Walker

Institutions: Creighton University, St. Joseph's Hospital and Medical Center, Dignity Health, Roswell Park Comprehensive Cancer Center, University at Buffalo, State University of New York, Abington Memorial Hospital, Magee-Womens Hospital, University of Pittsburgh Medical Center, Rush University Medical Center, University of Iowa, University of Iowa Hospitals and Clinics, Cancer Research for the Ozarks, University of Oklahoma

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G1950154987, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, Gynecologic Oncology Group, G70736214

OpenAlex ID: W2105928179

FWCI: 2.166

Cites: 27

Cited by: 17

Related to: 10